Back to home pageProfessional Education

Corewell Health is the new name for Beaumont.

The resident must meet the following requirements for employment at Corewell Health as the PGY-2 Critical Care resident:

  • licensed pharmacist or eligible for licensure in the State of Michigan (including controlled substance license)
  • successful completion of a PGY-1 ASHP accredited residency

Longitudinal Requirements

  • Active participation and support of residency recruitment activities
  • Complete the residency research project and initiate the incoming resident research project
  • Complete two (2) presentations for pharmacy noon conferences
  • Complete one (1) Medication Use Evaluation and present the findings
  • Complete four (4) Journal Club Presentations
  • Complete one (1) Pharmacy Grand Rounds presentation
  • Complete four (4) formal presentations
  • Present one (1) CE to Pharmacy Staff (extended residency project and/or another of resident’s choosing)
  • Update and maintain residency binder on Sharepoint and complete resident development plan on a quarterly basis
  • Consistent documentation of interventions (IVents, QSRs)
  • Complete weekend service requirements
  • Complete one major and one minor holiday service requirement
  • Participate in the Pharmacy On-Call Service
  • Support the precepting of Doctor of Pharmacy Students and PGY-1 Pharmacy Residents
  • Present the residency project at a regional pharmacy residency conference
  • Approval by the Research Committee of final manuscript for residency project
  • Submission of an acceptable manuscript to a peer reviewed journal
  • Achievement of 90% of the objectives for the required goals and have no educational objectives remaining in which the last assessment was recorded as needs improvement


 


Copyright © Corewell Health. All rights reserved.
Corewell Health
2021
Beaumont Logo
logo
Corewell Health is Michigan's largest health care system providing compassionate, extraordinary care to patient and families. Your partner in education and development.